For the quarter ending 2025-09-30, MRK made $17,276M in revenue. $5,785M in net income. Net profit margin of 33.49%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Sales | 17,276 | 15,806 | 15,529 | 15,624 |
| Cost of sales | 3,855 | 3,557 | 3,419 | 3,828 |
| Selling, general and administrative | 2,633 | 2,649 | 2,552 | 2,863 |
| Research and development | 4,234 | 4,048 | 3,621 | 4,584 |
| Restructuring costs | 47 | 560 | 69 | 50 |
| Other (income) expense, net | 238 | 7 | 35 | -129 |
| Total costs, expenses and other | 10,531 | 10,807 | 9,626 | 11,454 |
| Income before taxes | 6,745 | 4,999 | 5,903 | 4,170 |
| Taxes on income | 958 | 571 | 818 | 426 |
| Net income | 5,787 | 4,428 | 5,085 | 3,744 |
| Less net income attributable to noncontrolling interests | 2 | 1 | 6 | 1 |
| Net income attributable to merck & co., inc | 5,785 | 4,427 | 5,079 | 3,743 |
| Average common shares outstanding (in shares) | 2,495,000,000 | 2,510,000,000 | 2,523,000,000 | -5,069,000,000 |
| Average common shares outstanding assuming dilution (in shares) | 2,498,000,000 | 2,513,000,000 | 2,531,000,000 | -5,088,000,000 |
| Basic earnings per common share attributable to merck & co., inc. common shareholders (in dollars per share) | 2.32 | 1.76 | 2.01 | 1.48 |
| Earnings per common share assuming dilution attributable to merck & co., inc. common shareholders (in dollars per share) | 2.32 | 1.76 | 2.01 | 1.49 |
Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK)